Nerve block study aims to uncover Obesity-Hypertension link
NCT ID NCT05312892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how blocking certain nerve signals for two weeks changes the way the body produces sugar in people who have both obesity and high blood pressure. Twelve participants will receive a placebo, a blood pressure drug, or a nerve-blocking drug in a random order. The goal is to understand the body's sugar production better, not to treat the conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?